CYTEK BIOSCIENCES, INC. Contract Liability (Deferred Revenue)
CYTEK BIOSCIENCES, INC. (CTKB) had Contract Liability (Deferred Revenue) of $29.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Contract with Customer, Liability, Current $29.21M.
- 2026-03-31: Contract with Customer, Liability, Current $30.03M.
- 2025-12-31: Contract with Customer, Liability, Current $28.50M.
- 2025-09-30: Contract with Customer, Liability, Current $28.74M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $29.21M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $30.03M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $28.50M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $28.74M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $28.13M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $27.71M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $25.49M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $40.15M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $38.03M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $38.17M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $22.70M 10-K · filed 2025-02-28 | $37.83M 10-K · filed 2024-03-13 |
| 2023-09-30 | $38.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $36.67M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $31.12M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $26.11M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $22.50M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $21.01M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $19.45M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $16.87M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $13.63M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $10.98M 10-Q · filed 2021-09-03 | |
| 2020-12-31 | $7.12M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |